MIDAS Network Publications

Found 23 results
Filters: Keyword is Cost-Benefit Analysis  [Clear All Filters]
2010
Lee BY, Bailey RR, Wiringa AE, Afriyie A, Wateska AR, Smith KJ, Zimmerman RK.  2010.  Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza.. Vaccine. 28(37):5952-9.
Lee BY, H Y Tai J, Bailey RR, Smith KJ, Nowalk AJ.  2010.  Economics of influenza vaccine administration timing for children.. Am J Manag Care. 16(3):e75-e85.
Lee BY, Ufberg PJ, Bailey RR, Wiringa AE, Smith KJ, Nowalk AJ, Higgins C, Wateska AR, Muder RR.  2010.  The potential economic value of a Staphylococcus aureus vaccine for neonates.. Vaccine. 28(29):4653-60.
Lee BY, Bacon KM, Connor DL, Willig AM, Bailey RR.  2010.  The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America.. PLoS Negl Trop Dis. 4(12):e916.
Lee BY, Popovich MJ, Tian Y, Bailey RR, Ufberg PJ, Wiringa AE, Muder RR.  2010.  The potential value of Clostridium difficile vaccine: an economic computer simulation model.. Vaccine. 28(32):5245-53.
Lee BY, Wiringa AE, Bailey RR, Goyal V, G Lewis J, Tsui BYK, Smith KJ, Muder RR.  2010.  Screening cardiac surgery patients for MRSA: an economic computer model.. Am J Manag Care. 16(7):e163-73.
Lee BY, Wiringa AE, Bailey RR, G Lewis J, Feura J, Muder RR.  2010.  Staphylococcus aureus vaccine for orthopedic patients: an economic model and analysis.. Vaccine. 28(12):2465-71.
Lee BY, Bailey RR, Smith KJ, Muder RR, Strotmeyer ES, G Lewis J, Ufberg PJ, Song Y, Harrison LH.  2010.  Universal methicillin-resistant Staphylococcus aureus (MRSA) surveillance for adults at hospital admission: an economic model and analysis.. Infect Control Hosp Epidemiol. 31(6):598-606.